Medical

Tilray Announces Medical Cannabis Export to Chile

By: Soft Secrets, February 1, 2017

Tilray, a global leader in medical cannabis research and production, today announced that it has received necessary regulatory approvals in Canada and Chile to export medical cannabis for distribution to Chilean patients.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170201005120/en/
Tilray currently supplies pharmaceutical-grade medical cannabis products to thousands of patients, p …

Tilray currently supplies pharmaceutical-grade medical cannabis products to thousands of patients, physicians, pharmacies, hospitals, governments and researchers around the world. (PHOTO: Business Wire)

“Today’s announcement marks Tilray’s entry into Latin America and expands our international reach to a fourth continent,” said Brendan Kennedy, Tilray President. “We are proud to be able to offer patients in need access to high quality, pharmaceutical-grade medical cannabis products.”

Tilray is partnering with Alef Biotechnology SpA to import and distribute Tilray products in the country. Alef is licensed by the Chilean government to commercially produce medical cannabis. Chilean law permits patients to access medical cannabis products under the supervision of a recommending physician. Currently, there are an estimated 88,000 Chilean patients suffering from a diverse range of conditions who could benefit from medical cannabis. The first shipment of Tilray products is expected to arrive in Chile by the end of February and will initially be available at select hospitals and pharmacies in Santiago. In addition to handling distribution of Tilray products in Chile, Alef has been granted the exclusive rights to distribute Tilray products in Brazil as part of an agreement between the two companies.

“Alef Biotechnology is committed to improving the quality of life of patients in need,” said Roberto Roizman, President of the Alef Biotechnology Board. “By importing Tilray’s medical cannabis products to Chile we intend to ease the suffering of those in need by offering pure, precise and predictable medical cannabis products.”

Tilray currently supplies pharmaceutical-grade medical cannabis products – including whole flower, oils and capsules – to thousands of patients, physicians, pharmacies, hospitals, governments and researchers around the world for commercial, compassionate access and research purposes.

Tilray became the first medical cannabis producer in North America to be GMP certified in December 2016. GMP certification is the most rigorous standard that manufacturers of medical products must meet in their production processes, and it provides regulators and health care providers in countries new to medical cannabis with certainty that Tilray products are the safe and smart choice.

GMP certification is enabling Tilray to expand international distribution of its products. In 2016, Tilray made history by becoming the first company to legally export medical cannabis products from North America to Australia and the European Union. In 2017, the company is focused on expanding global distribution of its products to additional countries in Europe and Latin America.

GMP certification is also allowing Tilray to continue to break new ground in clinical research, advancing the science, safety and efficacy of medical cannabis for patients with a diverse range of conditions. Tilray currently supplies pharmaceutical-grade medical cannabis products for three different clinical trials in partnership with world-leading hospitals and universities:

The first trial is being conducted in partnership with the University of British Columbia to examine the safety and tolerability of medical cannabis for Canadian military veterans and other patients suffering from PTSD.
The second trial is being conducted in partnership with the University of Sydney, Chris O’Brien Lifehouse and the New South Wales government to study the safety, tolerability and efficacy of cannabinoids for chemotherapy-induced nausea and vomiting.
The third trial is examining safety and tolerability of cannabinoids in children with Dravet Syndrome (a severe form of treatment-resistant epilepsy) at Toronto’s Hospital for Sick Children.

Tilray plans to announce additional research partnerships in the coming year.

About Tilray

Tilray is a global leader in medical cannabis research and production dedicated to advancing the science, safety, and efficacy of medical cannabis. The company operates one of the largest and most sophisticated federally licensed medical cannabis cultivation facilities in the world, offering a range of products to patients, physicians, pharmacies, governments, hospitals and researchers in Australia, Canada, the European Union and Latin America.

About Alef Biotechnology

Alef Biotechnology is licensed by the Chilean government to commercially produce medical cannabis. The company is focused on medical cannabis research and development for the treatment of various medical condition. Its purpose is to increase the quality of life of those in pain, bringing dignity by developing innovative drugs and novel drug delivery systems to the market.

Share this article Linkedin Pinterest

Read more

Medical

5 different type of marijuana for depression and anxiety, according to the users.

By: Soft Secrets, December 11, 2018

The emergence of medical Marijuana has positively influenced various areas of medical sciences. Medical marijuana is of interest for treating mental health problems. In...

— Read More
Medical

How to Use CBD Oils

By: Soft Secrets, October 16, 2018

CBD oils have become the talk of the day thanks to the fact that they have amazing benefits on our bodies. They can be...

— Read More
Medical

Liposomal Delivery: Increasing The Efficiency & Potency Of CBD

By: Soft Secrets, September 26, 2018

CBD is the holistic treatment that has been a rising star in recent months. An increase in scientific study has broadened our understanding of...

— Read More
Medical

Dutch Passion medical cannabis projects announced in Australia, Colombia and Canada

By: Soft Secrets, August 13, 2018

Dutch Passion are pleased to announce important cannabis cultivation partnerships in Australia and Colombia with MYM Nutraceuticals and in Canada with Weed Me. The...

— Read More
SoftSecrets nu ook online

Soft Secrets now also available online

High-profile interviews and current news. Items that strike you and images to inspire you. But also sections on beauty, fashion, food, TV, music, art and film.

All magazines
x

We use cookies to give you the best possible online experience. By agreement you allow us to use cookies as indicated in our cookies policy.